Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)

ClinicalTrials.gov ID: NCT05550207

Public ClinicalTrials.gov record NCT05550207. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multiple-Dose Evaluation of the Efficacy and Safety of AXS-07 (Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor

Study identification

NCT ID
NCT05550207
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
100 participants

Conditions and interventions

Conditions

Interventions

  • AXS-07 (meloxicam-rizatriptan) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 30, 2022
Primary completion
Nov 26, 2024
Completion
Nov 26, 2024
Last update posted
Dec 1, 2025

2022 – 2024

United States locations

U.S. sites
31
U.S. states
15
U.S. cities
31
Facility City State ZIP Site status
Clinical Research Site Colton California 92324
Clinical Research Site Fullerton California 92835
Clinical Research Site La Jolla California 92037
Clinical Research Site Los Angeles California 90067
Clinical Research Site Sherman Oaks California 91403
Clinical Research Site Stamford Connecticut 06905
Clinical Research Site DeLand Florida 32720
Clinical Research Site Hallandale Florida 33009
Clinical Research Site Hollywood Florida 33024
Clinical Research Site Miami Florida 33126
Clinical Research Site Ormond Beach Florida 31274
Clinical Research Site Oviedo Florida 32765
Clinical Research Site Pensacola Florida 32504
Clinical Research Site Winter Park Florida 32789
Clinical Research Site Stockbridge Georgia 30281
Clinical Research Site Avon Indiana 46123
Clinical Research Site Boston Massachusetts 02131
Clinical Research Site North Dartmouth Massachusetts 02747
Clinical Research Site Las Vegas Nevada 89102
Clinical Research Site Albuquerque New Mexico 87102
Clinical Research Site The Bronx New York 10466
Clinical Research Site Williamsville New York 14221
Clinical Research Site Philadelphia Pennsylvania 19114
Clinical Research Site Charleston South Carolina 29406
Clinical Research Site Knoxville Tennessee 37909
Clinical Research Site Nashville Tennessee 37203
Clinical Research Site Cypress Texas 77429
Clinical Research Site Sugar Land Texas 77478
Clinical Research Site Salt Lake City Utah 84107
Clinical Research Site Charlottesville Virginia 22911
Clinical Research Site McLean Virginia 22101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05550207, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 1, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05550207 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →